Evommune, Inc. (EVMN)
NYSE: EVMN · Real-Time Price · USD
11.86
-0.36 (-2.95%)
Jul 22, 2026, 12:01 PM EDT - Market open
Evommune Market Cap
Evommune has a market cap or net worth of $427.18 million as of July 22, 2026.
Market Cap
427.18M
Enterprise Value
233.83M
1-Year Change
n/a
Ranking
Category
Stock Price
$11.86
ChartMarket Cap Chart
Since the IPO on November 6, 2025, Evommune's market cap has decreased from $481.24M to $427.18M, a decrease of -11.23%. That is a compound annual growth rate of -15.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 415.29M | -23.05% |
| Dec 31, 2025 | 539.69M | 12.15% |
| Nov 6, 2025 | 481.24M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cybin | 440.71M |
| Kyverna Therapeutics | 440.16M |
| Ovid Therapeutics | 430.21M |
| Puma Biotechnology | 422.47M |
| Benitec Biopharma | 411.22M |
| Eupraxia Pharmaceuticals | 410.29M |
| Prelude Therapeutics | 402.66M |
| vTv Therapeutics | 401.82M |